ALS, AU000000ALQ6

ALS updates automation thesis: ALS stock sits 26.10 percent below fair value

Published on 10/07/2026 at 00:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

For ALS stock, revenue growth assumptions rose from 10.03 to 10.74 percent. Fair value remains AUD 28.30 with a 26.10 percent intrinsic discount.

ALS, AU000000ALQ6, Illustration mit AI erstellt.
ALS, AU000000ALQ6, Illustration mit AI erstellt.

ALS (ISIN AU000000ALQ6) had its automation thesis updated on October 6, 2026, with fair value at AUD 28.30 and an intrinsic discount of 26.10 percent, according to Simply Wall St. The update shifts attention toward digital tools, automation and upgraded hub laboratories as potential drivers of operating leverage.

Automation changes the valuation case

The valuation work lifted its revenue growth assumption from 10.03 percent to 10.74 percent, while the discount rate rose from 7.42 percent to 7.54 percent, according to Simply Wall St on October 6, 2026. The combination matters because the revised thesis places greater weight on organic efficiency than on acquisition-led earnings growth.

The same update highlights unified laboratory information systems, internal artificial intelligence tools and lab robots as possible contributors to higher-value testing and throughput. It keeps fair value at AUD 28.30, making the 26.10 percent discount the central valuation comparison in the latest assessment.

Fiscal year 2026 gives the thesis support

ALS reported revenue of AUD 3.32 billion in fiscal year 2026, up 10.69 percent from AUD 2.9994 billion in fiscal year 2025, according to Reuters. Net income reached AUD 318.7 million in fiscal year 2026, compared with AUD 256.2 million in fiscal year 2025, a 24.39 percent increase.

That operating record gives the automation argument a measurable base, although the valuation update itself says the expected benefit depends on higher-value tests and improved throughput rather than broad sample-volume growth alone.

ASX range keeps the comparison concrete

ALS was last quoted at AUD 20.91 on the ASX on October 6, 2026. The 52-week range was AUD 19.28 to AUD 26.17, placing the quote 20.10 percent below the period high, while market capitalization stood at AUD 10.6 billion on the same date.

ALS describes itself as a global testing provider serving minerals, life sciences, energy and industrial customers. Its listing identity is ALS Limited on the ASX under ticker ALQ, matching the company and ISIN shown by ASX.

Reference level for the next session

The reference level at Lang & Schwarz is the prior close of EUR 13.10 on October 5, 2026.

The further course of trading is shown by the continuously updated real-time quote of ALS stock.

ALS stock facts

  • Company: ALS Limited
  • ISIN: AU000000ALQ6
  • Ticker: ALQ
  • Primary exchange: ASX
  • Prior close Lang & Schwarz (October 5, 2026): EUR 13.10
  • Market capitalization: AUD 10.6 billion (as of October 6, 2026)
  • 52-week range: AUD 19.28-AUD 26.17 (as of October 6, 2026)
  • Sector / Industry: Industrials / Consulting Services

More news and analyses on ALS stock

Disclaimer...

en | AU000000ALQ6 | ALS | boerse | 70246331 | bgmi